Reframing the Interpretation and Application of Exercise Electrocardiography∗  by Sinusas, Albert J. & Spatz, Erica S.
Journal of the American College of Cardiology Vol. 63, No. 13, 2014
 2014 by the American College of Cardiology Foundation ISSN 0735-1097/$36.00
Published by Elsevier Inc. http://dx.doi.org/10.1016/j.jacc.2013.12.026EDITORIAL COMMENTReframing the
Interpretation and
Application of Exercise
Electrocardiography*Albert J. Sinusas, MD, Erica S. Spatz, MD, MHS
New Haven, Connecticut
Guidelines recommend that most patients being evaluated
for ischemic heart disease (IHD) undergo exercise electro-
cardiography (ECG), provided that they are able to exercise
(1). Yet, despite more than 3 decades of data and experience,
the test continues to vex interpreting physicians and refer-
ring providers alike. Although ECG is recognized as
providing valuable information, ambivalence arises in esti-
mating the likelihood of disease on the basis of a test with a
reported sensitivity of only 68% and speciﬁcity of 77%, far
below the test performance of most other cardiovascular
imaging modalities.See page 1264Inherent to the interpretation of the exercise ECG is the
application of the Bayes theorem, or the process of proba-
bilistic reasoning. Simply stated, the predictive value of any
test result is conditional on the pre-test probability of disease.
These concepts were illustrated in Diamond and Forrester’s
landmark paper of 1979, demonstrating the likelihood of
coronary artery disease on the basis of an individual’s age, sex,
and symptoms as well as the magnitude of ST-segment
depression with exercise. In the ensuing 35 years, researchers
have leveraged other data associated with the exercise ECG
to improve the accuracy for detection of IHD, assess severity
of disease, and inform risk stratiﬁcation, including the eval-
uation of hemodynamic changes, exercise time, and symp-
toms. For example, the presence of angina and duration of
exercise, captured in the Duke Treadmill Score, have been
demonstrated to correlate with the risk of future events (2).
Many other electrocardiographic indexes beyond simple
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adjustment for ST-segment depression, QRS duration and
amplitude), although none of these indexes have been as
widely applied as the analysis of discrete ST-segment
depressions. These other previously established, more sen-
sitive or speciﬁc ECG indexes are rarely reported, and it is
not clear that they would change clinical practice (3,4).
In this issue of the Journal, Christman et al. (5) examine
speciﬁc exercise ECG ﬁndings and their association with the
use of additional diagnostic cardiovascular imaging tests as
well as cardiovascular outcomes (1). From a 10,000-ft view,
scoping the diagnostic evaluation of adults suspected of
having IHD is incredibly helpful for: 1) observing referral
patterns; 2) discovering knowledge gaps; and 3) identifying
areas for quality improvement; it is indeed the feedback
that every health system should provide. Unfortunately, the
overview engenders more questions than conclusions. For
example, it is impossible to judge whether the diagnostic
referral patterns observed in this study are the result of
probabilistic reasoning or the interpretation of test ﬁndings in
isolation. Without considering the patient’s pre-test pro-
bability of disease and risk of future events, only limited
conclusions can be drawn about the diagnostic utility of
exercise ECG and the appropriateness of downstream
testing. With respect to new knowledge, although the study
adds to the literature regarding the performance of speciﬁc
exercise ECG ﬁndings in detecting disease, there continue
to be salient questions about our ability to integrate test
ﬁndings into calculations of disease probability and deci-
sions regarding the next steps. Given these limitations, the
study’s impact may be greatest in identifying areas for
improvement. Questions about test performance and the
appropriateness of downstream testing are increasingly rele-
vant for the cardiovascular imaging community, particularly
in light of the recent advances in noninvasive diagnostic
testing modalities that have further expanded options for test
selection. It may be that interpreting physicians need to
reconsider their role in informing Bayesian decision-making.
Outcomes following the diagnostic evaluation of IHD of
3,345 individuals referred for exercise ECG to a high-
volume, academic stress laboratory were reviewed. The ex-
ercise ECG was reported as positive for ischemia in 3.7% of
individuals; most were negative (67.7%) or inconclusive
(28.5%). Additional downstream testing was performed
in approximately 1 in 10 adults, reﬂecting the myriad of
diagnostic modalities available for evaluating ischemia:
nuclear myocardial perfusion imaging (obtained in 65% of
individuals referred for a downstream test), stress echocar-
diogram (10%), coronary computed tomographic angiog-
raphy (4%), stress magnetic resonance imaging (1%), and
coronary angiography (20%). Despite the increased sensitivity
of more advanced diagnostic modalities, downstream testing
yielded relatively few positive test results, especially among
individuals with negative and inconclusive test ﬁndings,
perhaps suggesting referring providers’ overestimation of
disease probability or the limitations of all diagnostic tests.
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combined event-free survival from coronary revascularization,
myocardial infarction, and cardiovascular death was low.
These data provide important feedback; at the margins, the
exercise ECG remains a useful initial strategy for the risk
stratiﬁcation of individuals suspected of having IHD.
A second aim of the study was to determine whether new
insights may be gained from re-evaluating the reasons for
inconclusive test ﬁndings, which generated the bulk of
downstream testing. The authors found that individuals with
inconclusive tests because of “rapid recovery of ECG
changes” unanimously had normal ﬁndings on subsequent
diagnostic imaging tests, whereas those with inconclusive
tests because of “typical angina but no ECG changes” fre-
quently had a positive downstream test. These ﬁndings are
consistent with prior studies showing that transient ECG
changes and chest pain that occur with exercise ECG testing
are important diagnostic and prognostic indexes. The pres-
ence of chest pain was shown to be an important independent
predictor of coronary artery disease along with outcomes in
the 1970s and is a risk factor in the Duke Treadmill Score
used for prognosis (6,7). The clinical value of analyzing the
time to recovery of ST-segment depressions has also been
established in earlier studies (4). In fact, these earlier studies
suggested that it was necessary to perform a heart rate
adjustment for the recovery of exercise-induced ST-segment
depressions and that change in ST-segment/heart rate index
or evaluation of the ST-segment rate-recovery loop during
exercise testing improved the prognostic value (4).
Nonetheless, conclusions about the utility of speciﬁc
exercise ECG ﬁndings in the “inconclusive” group must be
interpreted with caution. For example, if only individuals
with a high pre-test probability were referred for additional
testing, then individuals with a low probability of disease
would not be accounted for when assessing the yield of
inconclusive test ﬁndings. This differential assessment leads
to “veriﬁcation bias,” or the inability to verify disease in all
subjects (because not everyone had a downstream test) (8).
Hence, the ﬁnding that 21% of individuals with “angina
but no ECG changes” had a positive downstream test may
be an overestimation of the true utility of this ﬁnding.
Another limitation in validating speciﬁc exercise ECG
ﬁndings with noninvasive cardiovascular imaging tests is that
most of the downstream tests performed in this study are not
considered gold standards of coronary artery disease. All
noninvasive imaging tests are inherently subject to delivering
false-positive and -negative results and cannot be used to
verify exercise ECG ﬁndings. This can be appreciated if we
consider the clinical signiﬁcance of exertional angina. As
outlined in the previous text, the presence of angina during
a physiological test to increase myocardial oxygen demand has
long been recognized as a predictor of outcomes, independent
of ECG ﬁndings (6,9). Similarly, angina without perfusion
defects or wall motion defects is also associated with adverse
events. These tests were designed to detect obstructive cor-
onary artery disease. However, microvascular disease orepicardial endothelial dysfunction may result in angina with
normal ECG, imaging, and even coronary catheterization
ﬁndings. Indeed, women with angina or other evidence of
ischemia but no obstructive coronary disease have poor out-
comes (10,11). As such, one must wonder whether patients
were harmed by receiving a negative downstream test result.
Developments in quantitative dynamic positron emission
tomography imaging may help advance our understanding of
this paradox. For example, diminished coronary ﬂow reserve,
a marker of microvascular disease, has been demonstrated
through the use of dynamic positron emission tomography
in patients with chest pain and normal epicardial arteries
(12). These and other developments have the potential to
transform test interpretation and risk assessment; however,
they must be correlated with patient outcomes.
Indeed, as the ﬁeld of advanced cardiac imaging grows,
it is increasingly more complex to determine the optimal
diagnostic work-up for patients suspected of IHD. Test
selection and interpretation requires knowing more than just
the pre-test probability of disease and the reported sensitivity
and speciﬁcity of the test (13). Consideration must be given
to the local quality of the test (both in its administration
and interpretation), the test’s performance in speciﬁc pop-
ulations, and how the test would affect patient treatment
and/or outcomes. Patient preferences must also be taken into
account. These aspects of test selection are nuanced for each
patient and must be considered when inferring the appro-
priateness of any downstream test, whether the optimal
imaging modality was selected, or whether patients beneﬁted
(or were harmed) by additional testing.
How canwe improve the yield of diagnostic tests and referral
patterns to investigate IHD? The cardiovascular imaging
community may be uniquely positioned to help shape the
diagnostic landscape. To do so, however, cardiovascular im-
aging specialists may need to reconsider the reporting of test
interpretations and their role in inﬂuencing disease manage-
ment. For example, a more expanded reporting framework may
consider questions such as: What is the patients’ baseline risk
for IHD? What are the speciﬁc test ﬁndings and what do
they indicate, even if discordant?What are the options for next
steps? What is at stake? Are there any risks in further testing?
Howmight downstream testing affectmanagement?What do
the guidelines offer?What is the cost? Ideally, the consultation
would serve as a clinical guide, facilitating more informed,
patient-centered discussions and decisions regarding next
steps. It would also serve as a roadmap for future investigative
work and technology, identifying gaps in knowledge and
opportunities for advancement. In this context, speciﬁc
ﬁndings from the exercise ECGmay promptmore thoughtful
decision-making, actually improving their diagnostic yield.
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